INDIRECT ALLORECOGNITION IN ACQUIRED THYMIC TOLERANCE: INDUCTION OF DONOR-SPECIFIC TOLERANCE TO RAT CARDIAC ALLOGRAFTS BY ALLOPEPTIDE-PULSED HOST DENDRITIC CELLS1,2
MEDIUM-TERM RESULTS OF HEART TRANSPLANTATION USING DONORS OVER 63 YEARS OF AGE1
CLINICAL BENEFIT OF NEORAL DOSE MONITORING WITH CYCLOSPORINE 2-HR POST-DOSE LEVELS COMPARED WITH TROUGH LEVELS IN STABLE HEART TRANSPLANT PATIENTS1
IMMUNOLOGIC FACTORS: THE MAJOR RISK FOR DECREASED LONG-TERM RENAL ALLOGRAFT SURVIVAL1,2
CHANGES IN PATTERNS OF 24-HR HEART RATE VARIABILITY AFTER KIDNEY AND KIDNEY-PANCREAS TRANSPLANT1,2
POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS IN ADULT AND PEDIATRIC RENAL TRANSPLANT PATIENTS RECEIVING TACROLIMUS-BASED IMMUNOSUPPRESSION1
FLOW CYTOMETRY-DETECTED IgG IS NOT A CONTRAINDICATION TO RENAL TRANSPLANTATION
RISK FACTORS FOR CANCER IN RENAL TRANSPLANT RECIPIENTS1
PREDNISONE WITHDRAWAL IN KIDNEY TRANSPLANT RECIPIENTS ON CYCLOSPORINE AND MYCOPHENOLATE MOFETIL-A PROSPECTIVE RANDOMIZED STUDY1,2
A NOVEL UNITED NETWORK FOR ORGAN SHARING REGION KIDNEY ALLOCATION PLAN IMPROVES TRANSPLANT ACCESS FOR MINORITY CANDIDATES1
ASSOCIATION BETWEEN CYTOMEGALOVIRUS DISEASE AND CHRONIC REJECTION IN KIDNEY TRANSPLANT RECIPIENTS1
INDUCTION OF ORGAN DYSFUNCTION AND UP-REGULATION OF INFLAMMATORY MARKERS IN THE LIVER AND KIDNEYS OF HYPOTENSIVE BRAIN DEAD RATS: A MODEL TO STUDY MARGINAL ORGAN DONORS1,2
CD4+CD25+ CELLS REGULATE CD8 CELL ANERGY IN NEONATAL TOLERANT MICE1,2
DONOR POLYMORPHISM OF TUMOR NECROSIS FACTOR GENE
TRANSDUCTION OF DENDRITIC CELL PROGENITORS WITH A RETROVIRAL VECTOR ENCODING VIRAL INTERLEUKIN-10 AND ENHANCED GREEN FLUORESCENT PROTEIN ALLOWS PURIFICATION OF POTENTIALLY TOLEROGENIC ANTIGEN-PRESENTING CELLS1,2
LONG-TERM GRAFT SURVIVAL AFTER TRANSPLANTATION WITH KIDNEYS FROM UNCONTROLLED NONHEARTBEATING DONORS1
FULMINANT HEPATIC FAILURE RESULTING FROM LAMIVUDINE-RESISTANT HEPATITIS B VIRUS IN A RENAL TRANSPLANT RECIPIENT
ANNOUNCEMENTS